31 related articles for article (PubMed ID: 15830276)
1. Delayed Rectifier K
Abe N; Toyama H; Saito K; Ejima Y; Yamauchi M; Mushiake H; Kazama I
Biomed Res Int; 2019; 2019():7567638. PubMed ID: 31828127
[TBL] [Abstract][Full Text] [Related]
2. Severe anasarca due to beriberi heart disease and diabetic nephropathy.
Toyonaga J; Masutani K; Tsuruya K; Haruyama N; Sugiwaka S; Suehiro T; Maeda H; Taniguchi M; Katafuchi R; Iida M
Clin Exp Nephrol; 2009 Oct; 13(5):518-521. PubMed ID: 19459028
[TBL] [Abstract][Full Text] [Related]
3. Translational mini-review series on complement factor H: therapies of renal diseases associated with complement factor H abnormalities: atypical haemolytic uraemic syndrome and membranoproliferative glomerulonephritis.
Noris M; Remuzzi G
Clin Exp Immunol; 2008 Feb; 151(2):199-209. PubMed ID: 18070148
[TBL] [Abstract][Full Text] [Related]
4. Comparison of pulse and oral steroid in childhood membranoproliferative glomerulonephritis.
Bahat E; Akkaya BK; Akman S; Karpuzoglu G; Guven AG
J Nephrol; 2007; 20(2):234-45. PubMed ID: 17514629
[TBL] [Abstract][Full Text] [Related]
5. Differences between membranoproliferative glomerulonephritis types I and III in long-term response to an alternate-day prednisone regimen.
Braun MC; West CD; Strife CF
Am J Kidney Dis; 1999 Dec; 34(6):1022-32. PubMed ID: 10585311
[TBL] [Abstract][Full Text] [Related]
6. Decrease of mesangial matrix after immunosuppressive therapy in children with reversible membranoproliferative glomerulonephritis type I.
Inaba S; Tanizawa T; Takahashi T; Ishihara S; Arai M; Sakai Y; Kurose KK; Matsukura H; Okada T
Clin Nephrol; 1996 Apr; 45(4):217-25. PubMed ID: 8861795
[TBL] [Abstract][Full Text] [Related]
7. IgA-associated glomerulonephritis with membranoproliferative glomerulonephritis-like pattern in two children.
Iitaka K; Yamamoto A; Ogawa N; Sekine T; Tamai S; Motoyama O
Clin Exp Nephrol; 2003 Dec; 7(4):284-9. PubMed ID: 14712358
[TBL] [Abstract][Full Text] [Related]
8. Long-term follow-up of type II membranoproliferative glomerulonephritis in two children.
Iitaka K; Nakamura S; Moriya S; Koshino H; Iwasaki N; Motoyama O; Sakai T
Clin Exp Nephrol; 2003 Mar; 7(1):58-62. PubMed ID: 14586745
[TBL] [Abstract][Full Text] [Related]
9. Steroid resistance in prolonged type I membranoproliferative glomerulonephritis and accelerated disease remission after steroid withdrawal.
Kazama I; Matsubara M; Ejima Y; Michimata M; Suzuki M; Miyama N; Sato A; Sato H; Ito S
Clin Exp Nephrol; 2005 Mar; 9(1):62-8. PubMed ID: 15830276
[TBL] [Abstract][Full Text] [Related]
10. Histopathological atlas of renal diseases. Membranoproliferative glomerulonephritis.
Ferrario F; Rastaldi MP
J Nephrol; 2004; 17(4):483-6. PubMed ID: 15372408
[TBL] [Abstract][Full Text] [Related]
11. A case of Kaposi's sarcoma following treatment of membranoproliferative glomerulonephritis and a review of the literature.
Agbaht K; Pepedil F; Kirkpantur A; Yilmaz R; Arici M; Turgan C
Ren Fail; 2007; 29(1):107-10. PubMed ID: 17365919
[TBL] [Abstract][Full Text] [Related]
12. [Mesangiocapillary glomerulonephritis].
Pál K; Nagy J
Orv Hetil; 1996 Jun; 137(26):1403-7. PubMed ID: 9182265
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
